Clinical Trials Browser

Recruiting × Breast Neoplasms × Ipilimumab × Clear all

NCT06324240 2026-01-26

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

Phase 1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06342037 2024-09-19

TONIC-3

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03815890 2024-05-30

BELLINI

Phase 2 Recruiting

Breast Neoplasms